相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 应用范围:
elisa
- 宿主:
0
- 适应物种:
Human
- 抗原来源:
0
- 库存:
大量
- 是否单克隆:
0
- 规格:
1 kit
VCAM-1 appears to have been highly conserved through evolution. Both rat and mouse VCAM-1 are highly homologous at the protein level to the human VCAM-1 (77% and 76%, respectively) [Hession et al., 1992].
VCAM-1 supports the adhesion of lymphocytes, monocytes, natural killer cells, eosinophils and basophils, through its interaction with integrin a4b1 (VLA-4). VCAM-1/VLA-4 interaction mediates firm adherence of circulating non-neutrophilic leukocytes to endothelium [Sharar et al., 1995]. VCAM-1 also participates in leukocyte adhesion outside of the vasculature, mediating precursor lymphocyte adhesion to bone marrow stromal cells [Ryan et al. 1991] and B cell binding to lymph node follicular dendritic cells [Feedman et al., 1992]. VCAM-1 is not constitutively expressed on endothelium, but can be up-regulated in vitro in response to LPS, TNF-a, and IL-1 [Carlos & Harlan, 1990; Osborn et al., 1989], as well as to interferon-g and IL-4 [Masinovsky et al. 1990]. VCAM-1 is also present on tissue macrophages, dendrite cells, bone marrow fibroblasts, myoblasts and myotubes.
A soluble form of VCAM-1 has been described [De Maeyer & De Maeyer-Buignard, 1995; Lobb et al., 1991], and soluble VCAM-1 has been found in serum [Gearing et al., 1995]. Increased levels of soluble VCAM-1 can be detected in several disease states, including cancer [Banks et al., 1993; Fortis et al., 1995; Gearing & Newman, 1993; Lai et al., 1995], autoimmune disorders [Gearing & Newman, 1993; Doreduffy et al., 1995; Gruschwitz et al., 1995; Mason et al., 1993; Mrowka & Sieberth, 1995; Spronk et al., 1994; Wellicome et al., 1993], infections [Jakobsen et al., 1994] and inflammations [Gearing & Newman, 1993; Mrowka & Sieberth, 1995; Adams et al., 1995; Lim et al., 1995].
Test Principle:
An anti-VCAM-1 monoclonal antibody is adsorbed onto microwells.
Soluble VCAM-1 present in a sample or standard then binds to antibodies adsorbed to the microwells. A mixture of biotin-conjugated monoclonal anti-VCAM-1 antibody and Streptavidin-HRP conjugate is added. Biotinylated anti-VCAM-1 antibody binds to VCAM-1 captured by the first antibody.
Streptavidin-HRP binds to the biotinylated anti-VCAM-1. Unbound biotinylated anti-VCAM-1 and Streptavidin-HRP conjugate is removed with a wash step and HRP substrate solution is added to the wells.
The pair of monoclonal antibodies used in this ELISA detect the soluble form of VCAM-1 present in serum, plasma, urine, and other biological fluids.
An amount of colored product is formed, proportional to the amount of soluble VCAM-1 present in the sample. The reaction is terminated by addition of acid and absorbance is measured at 450 nm. A standard curve is prepared from six soluble VCAM-1 standard dilutions and the VCAM-1 sample concentration is determined.
Application:
The VCAM-1 ELISA is an enzyme-linked immunosorbent assay for quantitative detection of soluble Vascular Cell Adhesion Molecule-1 in cell culture supernatants, serum, plasma, or other biological fluids. The VCAM-1 ELISA is for research use only. Not for use in diagnostic procedures.
- · 2 aluminum pouches with 3 Microwell Strips (16 wells per strip) coated with Monoclonal Antibody (murine) to human VCAM-1
- · 1 vial (0.1 mL) Conjugate Mixture containing Biotin-Conjugated Anti-VCAM-1 Monoclonal (murine) Antibody mixed with Streptavidin-HRP*
- · 2 vials (200 ng/mL as reconstituted) soluble VCAM-1 Standard, lyophilized*
- · 1 vial lyophilized control serum
- · 1 bottle (50 mL) Wash Buffer Concentrate 20X (PBS with 1% Tween 20)*
- · 1 vial (5 mL) Assay Buffer Concentrate 20X (PBS with 1% Tween 20 and 10% BSA)*
- · 1 vial (7 mL) Substrate Solution I (tetramethyl-benzidine)
- · 1 vial (7 mL) Substrate Solution II (0.02 % buffered hydrogen peroxide)
- · 1 vial (12 mL) Stop Solution (1M Phosphoric Acid, H3PO4), ready to use
- · 1 Microwell Strip Holder
- · 2 Adhesive Plate Covers
- · reagents containing 0.01% thimerosal as preservative
· Reagents are intended for research use only and are not for use in diagnostic or therapeutic procedures.
· Do not mix or substitute reagents with those from other lots or other sources.
· Do not use kit reagents beyond expiration date on label.
· Do not expose kit reagents to strong light during storage or incubation.
· Rubber or disposable latex gloves should be worn while handling kit reagents or specimens.
· Some reagents contain thimerosal as preservative, which is highly toxic by inhalation, ingestion, or contact with skin. Thimerosal is a possible mutagen and should be handled accordingly.
· Avoid contact of substrate solutions with oxidizing agents and metal.
· In order to avoid microbial contamination or cross-contamination of reagents or specimens which may invalidate the test use disposable pipette tips and/or pipettes.
· Use clean, dedicated reagent trays for dispensing the conjugate and substrate reagents.
· Exposure to acids will inactivate the conjugate.
· Glass-distilled water or deionized water must be used for reagent
preparation.
· Substrate solutions must be at room temperature prior to use.
· Since exact conditions may vary from assay to assay, a standard
curve must be established for every run.
· Bacterial or fungal contamination of either screen samples or reagents or cross-contamination between reagents may cause erroneous results.
· Disposable pipette tips, flasks or glassware are preferred. Reusable glassware must be washed and thoroughly rinsed of all detergents before use.
· Improper or insufficient washing at any stage of the procedure will result in either false positive or false negative results. Completely empty wells before dispensing fresh Wash Buffer, fill with Wash Buffer as indicated for each wash cycle and do not allow wells to sit uncovered or dry for extended periods.
· Any human anti-mouse IgG antibody (HAMA) present may interfere with assays utilizing murine monoclonal antibodies leading to both false positive and false negative results. HAMA interference can be reduced by adding murine immunoglobulins (serum, ascitic fluid, or monoclonal antibodies of irrelevant specificity) to the Sample Diluent.
- VCAM1
- INCAM-100
- MGC99561
- CD106
- DKFZp779G2333
- L1CAM
- 5 μL to 1000 μL adjustable single channel micropipettes with
disposable tips
- 50 μL to 300 μL adjustable multichannel micropipette with disposable tips
- Multichannel micropipette reservoir
- Beakers, flasks, cylinders necessary for preparation of reagents
- Device for delivery of wash solution (multichannel wash bottle or
automatic wash system)
- Microwell strip reader capable of reading at 450 nm (620 nm as
optional reference wavelength)
- Glass-distilled or deionized water
- Statistical calculator with program to perform linear regression analysis.
更多产品技术资讯,请访问密理博中国博客:http://blog.milliporechina.com
详细描述见链接:http://www.millipore.com/catalogue/item/ECM340
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验可检测到sICAM-1分子。目前尚未发现有可溶性ICAM-2和ICAM-3分子。 (五)可溶性VCAM-1(sVCAM-1) 关于sVCAM-1分子的报道较少,已知培养的活化内皮细胞可以释放sVCAM-1分子。sVCAM-1分子在80kDa和50kDa两种形式,其中80kDa分子的N端与膜结合VCAM-1是相同的。在脑脊液及滑膜液中也可有sVCAM-1分子存在。肿瘤与炎症患者血清中sVCAM-1可高于正常水平,在肾脏移植患者血清中sVCAM-1与肌酸酐小平
ELISA 试剂盒 货号 品 名 规格 价格 备注 F0001 人血管紧张素转化酶(Human ACE) 48T/96T 2000/3000 进口分装 F0002 激活素A(Activin A) 48T/96T 2000/3000 进口分装 F0003 ★ 人脂联素(human Adiponectin) 48T/96T 1500/2500 进口分装 F0004 白细胞活化黏附因子(ALCAM) 48T/96
因子 >>> 分装 ELISA 试剂盒 货号 品名 方法 规格 价格 备注 F00010 血管紧张素转化酶 (Human ACE) ELISA 48T/96T 2000/3000 进口分装 F00020 激活素 A(Activin A) ELISA 48T/96T 2000/3000 进口分装 F00021 雄激素结合蛋白 (ABP) ELISA 48T/96T 1800/2800 进口分装 F00022 促肾上腺皮质激素 (ACTH) ELISA 48T/96
技术资料暂无技术资料 索取技术资料





